Fair Genomics: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Fair Genomics
Largest movements
- Cash +€14,250
up €14,250 (+415%), from €3,433 to €17,683
mainly Trade debts (+€39,059) and Depreciation (+€19,880)
- Receivables within one year -€8,752
down €8,752 (-22.4%), from €39,075 to €30,323
of which Trade receivables: -€10,068
- Intangible fixed assets +€4,990
up €4,990 (+8.8%), from €56,859 to €61,849
- Trade debts +€39,059
up €39,059 (+1,134%), from €3,445 to €42,504
- Profit (loss) carried forward -€38,618
down €38,618 (-44.8%), from €86,147 to €47,529
- Tax, wage and social debts +€8,672
up €8,672 (+97.8%), from €8,863 to €17,535
of which Remuneration and social security: +€9,370
- Staff costs +€31,871
up €31,871 (+91.8%), from €34,706 to €66,576
- Gross operating margin -€28,723
down €28,723 (-37.1%), from €77,343 to €48,620
- Taxes -€5,601
down €5,601, from €5,598 to -€3
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €105,924 | €115,243 | +€9,319 | +8.8% |
| Fixed assets | 21/28 | €59,759 | €63,879 | +€4,120 | +6.9% |
| Intangible fixed assets | 21 | €56,859 | €61,849 | +€4,990 | +8.8% |
| Tangible fixed assets | 22/27 | €2,163 | €1,294 | -€869 | -40.2% |
| Furniture and vehicles | 24 | €2,163 | €1,294 | -€869 | -40.2% |
| Financial fixed assets | 28 | €736 | €736 | = | 0.0% |
| Current assets | 29/58 | €46,165 | €51,364 | +€5,199 | +11.3% |
| Amounts receivable within one year | 40/41 | €39,075 | €30,323 | -€8,752 | -22.4% |
| Trade receivables | 40 | €10,087 | €19 | -€10,068 | -99.8% |
| Other amounts receivable | 41 | €28,988 | €30,304 | +€1,316 | +4.5% |
| Cash at bank and in hand | 54/58 | €3,433 | €17,683 | +€14,250 | +415% |
| Deferred charges and accrued income | 490/1 | €3,657 | €3,357 | -€299 | -8.2% |
| Total equity and liabilities | 10/49 | €105,924 | €115,243 | +€9,319 | +8.8% |
| Equity | 10/15 | €91,197 | €52,579 | -€38,618 | -42.3% |
| Contributions | 10/11 | €5,050 | €5,050 | = | 0.0% |
| Profit (loss) carried forward | 14 | €86,147 | €47,529 | -€38,618 | -44.8% |
| Amounts payable | 17/49 | €14,727 | €62,664 | +€47,937 | +326% |
| Amounts payable within one year | 42/48 | €14,727 | €62,487 | +€47,760 | +324% |
| Trade debts | 44 | €3,445 | €42,504 | +€39,059 | +1,134% |
| Suppliers | 440/4 | €3,445 | €42,504 | +€39,059 | +1,134% |
| Taxes, remuneration and social security | 45 | €8,863 | €17,535 | +€8,672 | +97.8% |
| Taxes | 450/3 | €699 | €0 | -€699 | -100% |
| Remuneration and social security | 454/9 | €8,165 | €17,535 | +€9,370 | +115% |
| Other amounts payable | 47/48 | €2,419 | €2,449 | +€30 | +1.2% |
| Accrued charges and deferred income | 492/3 | - | €177 | +€177 | |
| Remuneration, social security and pensions | 62 | €34,706 | €66,576 | +€31,871 | +91.8% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €19,838 | €19,880 | +€42 | +0.2% |
| Other operating charges | 640/8 | €387 | €400 | +€12 | +3.2% |
| Gross operating margin | 9900 | €77,343 | €48,620 | -€28,723 | -37.1% |
| Operating profit (loss) | 9901 | €22,412 | -€38,236 | -€60,648 | |
| Financial charges | 65/66B | €227 | €386 | +€158 | +69.6% |
| Recurring financial charges | 65 | €227 | €386 | +€158 | +69.6% |
| Profit (loss) for the period before taxes | 9903 | €22,185 | -€38,621 | -€60,806 | |
| Income taxes | 67/77 | €5,598 | -€3 | -€5,601 | |
| Profit (loss) for the period | 9904 | €16,587 | -€38,618 | -€55,205 | |
| Profit (loss) for the period to be appropriated | 9905 | €16,587 | -€38,618 | -€55,205 |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 23 October 2026 via checked.be.